C9orf72 and amyotrophic lateral sclerosis: Meanwhile, owing to the lack of behavioral phenotypes and other neurodegenerative features in the current C9orf72 animal models, the protective effects of the CRISPR/Cas13d system in C9-ALS/FTD patients require further evaluation.